Research Article
High-Sensitivity Troponin T and Copeptin in Non-ST Acute Coronary Syndromes: Implications for Prognosis and Role of hsTnT and Copeptin in Non-STEACS
Table 2
hsTnT levels in relation to different modalities of drug therapy.
| Therapy | hsTnT levels (ng/mL) | value |
| Aspirin | Yes: 0.014 (0.007–0.027) | 0.583 | No: 0.008 (0.008–0.008) | Clopidogrel | Yes: 0.013 (0.001–0.026) | 0.383 | No: 0.029 (0.029–0.029) | ARBs | Yes: 0.009 (0.004–0.016) | 0.557 | No: 0.010 (0.005–0.026) | Beta-blocker | Yes: 0.011 (0.005–0.026) | 0.478 | No: 0.009 (0.004–0.021) | ACE inhibitors | Yes: 0.010 (0.005–0.023) | 0.771 | No: 0.009 (0.005–0.024) | CA | Yes: 0.012 (0.007–0.023) | 0.370 | No: 0.009 (0.004–0.021) | Statins | Yes: 0.013 (0.005–0.029) | 0.087 | No: 0.009 (0.004–0.029) |
|
|
Values are median (IQR). ARBs: angiotensin receptor blockers; ACE: angiotensin-converting enzyme; CA: calcium antagonists.
|